APO Research, Inc.

APO RESEARCH · REPORT

Cell and Gene Therapy Cold Chain Logistics

Selected research

Market Structure

Global Cell and Gene Therapy Cold Chain Logistics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Cell and Gene Therapy Cold Chain Logistics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Cell and Gene Therapy Cold Chain Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cell and Gene Therapy Cold Chain Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell and Gene Therapy Cold Chain Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cell and Gene Therapy Cold Chain Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cell and Gene Therapy Cold Chain Logistics include AmerisourceBergen Corporation, Arvato Supply Chain Solutions SE, Be The Match BioTherapies, BioLife Solutions, Cardinal Health, Catalent, Cryoport, BioStor Sytems and Marken, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Cell and Gene Therapy Cold Chain Logistics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cell and Gene Therapy Cold Chain Logistics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cell and Gene Therapy Cold Chain Logistics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cell and Gene Therapy Cold Chain Logistics market size, projected growth trends, production technologies, key applications, and end-use industries.

Cell and Gene Therapy Cold Chain Logistics Segment by Company

AmerisourceBergen Corporation

Arvato Supply Chain Solutions SE

Be The Match BioTherapies

BioLife Solutions

Cardinal Health

Catalent

Cryoport

BioStor Sytems

Marken

Polar Express Transportation

Thermo Fisher Scientific

Yourway Biopharma Services Company

Cell and Gene Therapy Cold Chain Logistics Segment by Type

Air Freight

Ground Transportation

Water Transport

Cell and Gene Therapy Cold Chain Logistics Segment by Application

Biopharmaceutical & Biotechnology Companies

Academic & Research Institutes

Others

Cell and Gene Therapy Cold Chain Logistics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy Cold Chain Logistics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy Cold Chain Logistics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy Cold Chain Logistics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cell and Gene Therapy Cold Chain Logistics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell and Gene Therapy Cold Chain Logistics industry.

Chapter 3: Detailed analysis of Cell and Gene Therapy Cold Chain Logistics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell and Gene Therapy Cold Chain Logisticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell and Gene Therapy Cold Chain Logistics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Air Freight Table 3. Key Players of Ground Transportation Table 4. Key Players of Water Transport Table 4. Global Cell and Gene Therapy Cold Chain Logistics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Biopharmaceutical & Biotechnology Companies Table 6. Key Players of Academic & Research Institutes Table 7. Key Players of Others Table 8. Global Cell and Gene Therapy Cold Chain Logistics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Cell and Gene Therapy Cold Chain Logistics Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Cell and Gene Therapy Cold Chain Logistics Market Share by Region (2021-2026) Table 11. Global Cell and Gene Therapy Cold Chain Logistics Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Cell and Gene Therapy Cold Chain Logistics Market Share by Region (2027-2032) Table 13. Cell and Gene Therapy Cold Chain Logistics Industry Trends Table 14. Cell and Gene Therapy Cold Chain Logistics Industry Drivers Table 15. Cell and Gene Therapy Cold Chain Logistics Industry Opportunities and Challenges Table 16. Cell and Gene Therapy Cold Chain Logistics Industry Restraints Table 17. Global Cell and Gene Therapy Cold Chain Logistics Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Company (2021-2026) Table 19. Global Cell and Gene Therapy Cold Chain Logistics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Cell and Gene Therapy Cold Chain Logistics Key Company Head Office and Area Served Table 21. Global Cell and Gene Therapy Cold Chain Logistics Company, Product Type & Application Table 22. Global Cell and Gene Therapy Cold Chain Logistics Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Cell and Gene Therapy Cold Chain Logistics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Cell and Gene Therapy Cold Chain Logistics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Type (2021-2026) Table 29. Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Type (2027-2032) Table 30. Global Cell and Gene Therapy Cold Chain Logistics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Application (2021-2026) Table 34. Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Application (2027-2032) Table 35. AmerisourceBergen Corporation Company Information Table 36. AmerisourceBergen Corporation Business Overview Table 37. AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 39. AmerisourceBergen Corporation Recent Development Table 40. Arvato Supply Chain Solutions SE Company Information Table 41. Arvato Supply Chain Solutions SE Business Overview Table 42. Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 44. Arvato Supply Chain Solutions SE Recent Development Table 45. Be The Match BioTherapies Company Information Table 46. Be The Match BioTherapies Business Overview Table 47. Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 49. Be The Match BioTherapies Recent Development Table 50. BioLife Solutions Company Information Table 51. BioLife Solutions Business Overview Table 52. BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 54. BioLife Solutions Recent Development Table 55. Cardinal Health Company Information Table 56. Cardinal Health Business Overview Table 57. Cardinal Health Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Cardinal Health Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 59. Cardinal Health Recent Development Table 60. Catalent Company Information Table 61. Catalent Business Overview Table 62. Catalent Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Catalent Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 64. Catalent Recent Development Table 65. Cryoport Company Information Table 66. Cryoport Business Overview Table 67. Cryoport Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Cryoport Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 69. Cryoport Recent Development Table 70. BioStor Sytems Company Information Table 71. BioStor Sytems Business Overview Table 72. BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 74. BioStor Sytems Recent Development Table 75. Marken Company Information Table 76. Marken Business Overview Table 77. Marken Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Marken Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 79. Marken Recent Development Table 80. Polar Express Transportation Company Information Table 81. Polar Express Transportation Business Overview Table 82. Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 84. Polar Express Transportation Recent Development Table 85. Thermo Fisher Scientific Company Information Table 86. Thermo Fisher Scientific Business Overview Table 87. Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 89. Thermo Fisher Scientific Recent Development Table 90. Yourway Biopharma Services Company Company Information Table 91. Yourway Biopharma Services Company Business Overview Table 92. Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 94. Yourway Biopharma Services Company Recent Development Table 95. North America Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2021-2026) & (US$ Million) Table 96. North America Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2027-2032) & (US$ Million) Table 97. North America Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2021-2026) & (US$ Million) Table 98. North America Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2027-2032) & (US$ Million) Table 99. North America Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2021-2026) Table 101. North America Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2027-2032) Table 102. Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2021-2026) & (US$ Million) Table 103. Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2027-2032) & (US$ Million) Table 104. Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2021-2026) & (US$ Million) Table 105. Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2027-2032) & (US$ Million) Table 106. Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2021-2026) Table 108. Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2027-2032) Table 109. China Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2021-2026) & (US$ Million) Table 110. China Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2027-2032) & (US$ Million) Table 111. China Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2021-2026) & (US$ Million) Table 112. China Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2027-2032) & (US$ Million) Table 113. Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2021-2026) & (US$ Million) Table 114. Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2027-2032) & (US$ Million) Table 115. Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2021-2026) & (US$ Million) Table 116. Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2027-2032) & (US$ Million) Table 117. Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2021-2026) Table 119. Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2027-2032) Table 120. South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2021-2026) & (US$ Million) Table 121. South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2027-2032) & (US$ Million) Table 122. South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2021-2026) Table 126. South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Cell and Gene Therapy Cold Chain Logistics Product Image Figure 2. Global Cell and Gene Therapy Cold Chain Logistics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Cell and Gene Therapy Cold Chain Logistics Market Share by Type: 2025 VS 2032 Figure 4. Air Freight Image Figure 5. Ground Transportation Image Figure 6. Water Transport Image Figure 7. Global Cell and Gene Therapy Cold Chain Logistics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Cell and Gene Therapy Cold Chain Logistics Market Share by Application: 2025 VS 2032 Figure 9. Biopharmaceutical & Biotechnology Companies Image Figure 10. Academic & Research Institutes Image Figure 11. Others Image Figure 12. Global Cell and Gene Therapy Cold Chain Logistics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 14. Global Cell and Gene Therapy Cold Chain Logistics Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Cell and Gene Therapy Cold Chain Logistics Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Cell and Gene Therapy Cold Chain Logistics Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Type (2021-2032) Figure 21. Global Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Application (2021-2032) Figure 23. North America Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 24. North America Cell and Gene Therapy Cold Chain Logistics Market Share by Type (2021-2032) Figure 25. North America Cell and Gene Therapy Cold Chain Logistics Market Share by Application (2021-2032) Figure 26. North America Cell and Gene Therapy Cold Chain Logistics Market Share by Country (2021-2032) Figure 27. United States Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 28. Canada Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 30. Europe Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 31. Europe Cell and Gene Therapy Cold Chain Logistics Market Share by Type (2021-2032) Figure 32. Europe Cell and Gene Therapy Cold Chain Logistics Market Share by Application (2021-2032) Figure 33. Europe Cell and Gene Therapy Cold Chain Logistics Market Share by Country (2021-2032) Figure 34. Germany Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 35. France Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 37. Italy Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 38. Russia Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 40. China Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 41. China Cell and Gene Therapy Cold Chain Logistics Market Share by Type (2021-2032) Figure 42. China Cell and Gene Therapy Cold Chain Logistics Market Share by Application (2021-2032) Figure 43. Asia Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 44. Asia Cell and Gene Therapy Cold Chain Logistics Market Share by Type (2021-2032) Figure 45. Asia Cell and Gene Therapy Cold Chain Logistics Market Share by Application (2021-2032) Figure 46. Asia Cell and Gene Therapy Cold Chain Logistics Market Share by Country (2021-2032) Figure 47. Japan Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 51. India Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 52. Australia Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Share by Country (2021-2032) Figure 57. Brazil Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 62. UAE Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 64. Chile Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Air Freight
  • Ground Transportation
  • Water Transport
Applications
  • Biopharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others
Companies covered
  • AmerisourceBergen Corporation
  • Arvato Supply Chain Solutions SE
  • Be The Match BioTherapies
  • BioLife Solutions
  • Cardinal Health
  • Catalent
  • Cryoport
  • BioStor Sytems
  • Marken
  • Polar Express Transportation
  • Thermo Fisher Scientific
  • Yourway Biopharma Services Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Cell and Gene Therapy Cold Chain Logistics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Air Freight
  5. 1.2.3 Ground Transportation
  6. 1.2.4 Water Transport
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Cell and Gene Therapy Cold Chain Logistics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Biopharmaceutical & Biotechnology Companies
  10. 1.3.3 Academic & Research Institutes
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Cell and Gene Therapy Cold Chain Logistics Growth Trends by Region
  14. 1.5.1 Global Cell and Gene Therapy Cold Chain Logistics Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Cell and Gene Therapy Cold Chain Logistics Market Size by Region (2021-2026)
  16. 1.5.3 Cell and Gene Therapy Cold Chain Logistics Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Cell and Gene Therapy Cold Chain Logistics Market Dynamics
  1. 2.1 Cell and Gene Therapy Cold Chain Logistics Industry Trends
  2. 2.2 Cell and Gene Therapy Cold Chain Logistics Industry Drivers
  3. 2.3 Cell and Gene Therapy Cold Chain Logistics Industry Opportunities and Challenges
  4. 2.4 Cell and Gene Therapy Cold Chain Logistics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Cell and Gene Therapy Cold Chain Logistics Revenue by Company (2021-2026)
  2. 3.2 Global Cell and Gene Therapy Cold Chain Logistics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Cell and Gene Therapy Cold Chain Logistics Key Company Head office and Area Served
  4. 3.4 Global Cell and Gene Therapy Cold Chain Logistics Company, Product Type & Application
  5. 3.5 Global Cell and Gene Therapy Cold Chain Logistics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Cell and Gene Therapy Cold Chain Logistics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Cell and Gene Therapy Cold Chain Logistics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Cell and Gene Therapy Cold Chain Logistics Tier 1, Tier 2, and Tier 3
4 Cell and Gene Therapy Cold Chain Logistics Market by Type
  1. 4.1 Global Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2021-2032)
  3. 4.3 Global Cell and Gene Therapy Cold Chain Logistics Market Size Share by Type (2021-2032)
5 Cell and Gene Therapy Cold Chain Logistics Market by Application
  1. 5.1 Global Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2021-2032)
  3. 5.3 Global Cell and Gene Therapy Cold Chain Logistics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AmerisourceBergen Corporation
  2. 6.1.1 AmerisourceBergen Corporation Company Information
  3. 6.1.2 AmerisourceBergen Corporation Business Overview
  4. 6.1.3 AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  6. 6.1.5 AmerisourceBergen Corporation Recent Developments
  7. 6.2 Arvato Supply Chain Solutions SE
  8. 6.2.1 Arvato Supply Chain Solutions SE Company Information
  9. 6.2.2 Arvato Supply Chain Solutions SE Business Overview
  10. 6.2.3 Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  12. 6.2.5 Arvato Supply Chain Solutions SE Recent Developments
  13. 6.3 Be The Match BioTherapies
  14. 6.3.1 Be The Match BioTherapies Company Information
  15. 6.3.2 Be The Match BioTherapies Business Overview
  16. 6.3.3 Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  18. 6.3.5 Be The Match BioTherapies Recent Developments
  19. 6.4 BioLife Solutions
  20. 6.4.1 BioLife Solutions Company Information
  21. 6.4.2 BioLife Solutions Business Overview
  22. 6.4.3 BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  24. 6.4.5 BioLife Solutions Recent Developments
  25. 6.5 Cardinal Health
  26. 6.5.1 Cardinal Health Company Information
  27. 6.5.2 Cardinal Health Business Overview
  28. 6.5.3 Cardinal Health Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Cardinal Health Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  30. 6.5.5 Cardinal Health Recent Developments
  31. 6.6 Catalent
  32. 6.6.1 Catalent Company Information
  33. 6.6.2 Catalent Business Overview
  34. 6.6.3 Catalent Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Catalent Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  36. 6.6.5 Catalent Recent Developments
  37. 6.7 Cryoport
  38. 6.7.1 Cryoport Company Information
  39. 6.7.2 Cryoport Business Overview
  40. 6.7.3 Cryoport Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Cryoport Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  42. 6.7.5 Cryoport Recent Developments
  43. 6.8 BioStor Sytems
  44. 6.8.1 BioStor Sytems Company Information
  45. 6.8.2 BioStor Sytems Business Overview
  46. 6.8.3 BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  48. 6.8.5 BioStor Sytems Recent Developments
  49. 6.9 Marken
  50. 6.9.1 Marken Company Information
  51. 6.9.2 Marken Business Overview
  52. 6.9.3 Marken Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Marken Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  54. 6.9.5 Marken Recent Developments
  55. 6.10 Polar Express Transportation
  56. 6.10.1 Polar Express Transportation Company Information
  57. 6.10.2 Polar Express Transportation Business Overview
  58. 6.10.3 Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  60. 6.10.5 Polar Express Transportation Recent Developments
  61. 6.11 Thermo Fisher Scientific
  62. 6.11.1 Thermo Fisher Scientific Company Information
  63. 6.11.2 Thermo Fisher Scientific Business Overview
  64. 6.11.3 Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  66. 6.11.5 Thermo Fisher Scientific Recent Developments
  67. 6.12 Yourway Biopharma Services Company
  68. 6.12.1 Yourway Biopharma Services Company Company Information
  69. 6.12.2 Yourway Biopharma Services Company Business Overview
  70. 6.12.3 Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  72. 6.12.5 Yourway Biopharma Services Company Recent Developments
7 North America
  1. 7.1 North America Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032)
  2. 7.2 North America Cell and Gene Therapy Cold Chain Logistics Market Size by Type
  3. 7.2.1 North America Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2021-2026)
  4. 7.2.2 North America Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2027-2032)
  5. 7.2.3 North America Cell and Gene Therapy Cold Chain Logistics Market Share by Type (2021-2032)
  6. 7.3 North America Cell and Gene Therapy Cold Chain Logistics Market Size by Application
  7. 7.3.1 North America Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2021-2026)
  8. 7.3.2 North America Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2027-2032)
  9. 7.3.3 North America Cell and Gene Therapy Cold Chain Logistics Market Share by Application (2021-2032)
  10. 7.4 North America Cell and Gene Therapy Cold Chain Logistics Market Size by Country
  11. 7.4.1 North America Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2021-2026)
  13. 7.4.3 North America Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2027-2032)
  14. 7.4.4 North America Cell and Gene Therapy Cold Chain Logistics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032)
  2. 8.2 Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Type
  3. 8.2.1 Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Cell and Gene Therapy Cold Chain Logistics Market Share by Type (2021-2032)
  6. 8.3 Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Application
  7. 8.3.1 Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Cell and Gene Therapy Cold Chain Logistics Market Share by Application (2021-2032)
  10. 8.4 Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Country
  11. 8.4.1 Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Cell and Gene Therapy Cold Chain Logistics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032)
  2. 9.2 China Cell and Gene Therapy Cold Chain Logistics Market Size by Type
  3. 9.2.1 China Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2021-2026)
  4. 9.2.2 China Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2027-2032)
  5. 9.2.3 China Cell and Gene Therapy Cold Chain Logistics Market Share by Type (2021-2032)
  6. 9.3 China Cell and Gene Therapy Cold Chain Logistics Market Size by Application
  7. 9.3.1 China Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2021-2026)
  8. 9.3.2 China Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2027-2032)
  9. 9.3.3 China Cell and Gene Therapy Cold Chain Logistics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032)
  2. 10.2 Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Type
  3. 10.2.1 Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Cell and Gene Therapy Cold Chain Logistics Market Share by Type (2021-2032)
  6. 10.3 Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Application
  7. 10.3.1 Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Cell and Gene Therapy Cold Chain Logistics Market Share by Application (2021-2032)
  10. 10.4 Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Country
  11. 10.4.1 Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Cell and Gene Therapy Cold Chain Logistics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Cell and Gene Therapy Cold Chain Logistics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.